A. Panighini

Receptor crosstalk: haloperidol treatment enhances A2A adenosine receptor functioning in a transfected cell model

K. Klotz, M. Trincavelli, C. Martini, 2010, Purinergic Signalling.

Vascular Dysfunction in a Mouse Model of Rett Syndrome and Effects of Curcumin Treatment

N. Funel, F. Santini, T. Pizzorusso, 2013, PloS one.

Visual impairment in FOXG1-mutated individuals and mice

E. Strettoi, E. Novelli, T. Pizzorusso, 2016, Neuroscience.

Expanding the phenotype associated with FOXG1 mutations and in vivo FoxG1 chromatin‐binding dynamics

F. Cardarelli, A. Renieri, F. Mari, 2012, Clinical genetics.

Platelet uptake of GABA and glutamate in patients with bipolar disorder.

C. Martini, G. Cassano, M. Abelli, 2012, Bipolar disorders.

The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model

C. Fiorentini, M. Caleo, Mario Costa, 2014, BMC Cancer.

A2A Adenosine Receptor Binding Parameters in Platelets from Patients Affected by Pathological Gambling

M. Trincavelli, C. Martini, E. Da Pozzo, 2011, Neuropsychobiology.

The oral reversibly-binding antiplatelet agent, Ticagrelor, acts as an antagonist at the P2Y-like receptor GPR17

M. Trincavelli, C. Martini, S. Daniele, 2010 .

Synthesis and Antihypertensive Action of New Imidazo[1,2-a]pyridine Derivatives , non Peptidic Angiotensin II Receptor Antagonists.

C. Martini, S. Laneri, A. Sacchi, 2011, Cardiovascular & Haematological Disorders - Drug Targets.